Axonal transport rates in vivo are unaltered in htau mice
暂无分享,去创建一个
Takahiro Sasaki | R. Nixon | K. Duff | Asok Kumar | A. Yuan
[1] Jean-Pierre Julien,et al. Axonal transport deficits and neurodegenerative diseases , 2013, Nature Reviews Neuroscience.
[2] A. Andreadis,et al. Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.
[3] L. Greensmith,et al. Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. , 2011, Human molecular genetics.
[4] Han Lin,et al. Increased Human Wildtype Tau Attenuates Axonal Transport Deficits Caused by Loss of APP in Mouse Models. , 2010, Magnetic resonance insights.
[5] A. Kozikowski,et al. The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicity , 2009, Journal of neuroscience research.
[6] Aidong Yuan,et al. Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice , 2008, The Journal of Neuroscience.
[7] A. Takashima,et al. Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild‐type human tau , 2007, The EMBO journal.
[8] J. Trojanowski,et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.
[9] M. Kikkawa,et al. Tau binding to microtubules does not directly affect microtubule‐based vesicle motility , 2007, Journal of neuroscience research.
[10] B. C. Carter,et al. Multiple-motor based transport and its regulation by Tau , 2007, Proceedings of the National Academy of Sciences.
[11] Veeranna,et al. α-Internexin Is Structurally and Functionally Associated with the Neurofilament Triplet Proteins in the Mature CNS , 2006, The Journal of Neuroscience.
[12] B. Winblad,et al. Assessments of the accumulation severities of amyloid β-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains , 2006, Neurobiology of Disease.
[13] P. Hof,et al. Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms , 2005, The Journal of Neuroscience.
[14] Chi Li,et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] Bin Zhang,et al. Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy , 2004, The Journal of Neuroscience.
[16] D. Price,et al. Axonal transport of human α‐synuclein slows with aging but is not affected by familial Parkinson's disease‐linked mutations , 2003, Journal of neurochemistry.
[17] J. Julien,et al. Neurofilament Transport In Vivo Minimally Requires Hetero-Oligomer Formation , 2003, The Journal of Neuroscience.
[18] M. Feany,et al. Polyglutamines Stop Traffic Axonal Transport as a Common Target in Neurodegenerative Diseases , 2003, Neuron.
[19] P. Davies,et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.
[20] S. Leurgans,et al. Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's Disease , 2002, Experimental Neurology.
[21] A. Lees,et al. The Slow Axonal Transport of the Microtubule-Associated Protein Tau and the Transport Rates of Different Isoforms and Mutants in Cultured Neurons , 2002, The Journal of Neuroscience.
[22] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[23] P. Davies,et al. Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau Transgenes , 2000, Neurobiology of Disease.
[24] J. Price,et al. Formation of diffuse and fibrillar tangles in aging and early Alzheimer’s disease☆ , 2000, Neurobiology of Aging.
[25] Bin Zhang,et al. Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.
[26] E. Mandelkow,et al. Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.
[27] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[28] M. Mercken,et al. Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[29] J. Skene,et al. The 25 kDa synaptosomal-associated protein SNAP-25 is the major methionine-rich polypeptide in rapid axonal transport and a major substrate for palmitoylation in adult CNS , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] I. Grundke‐Iqbal,et al. Brain Levels of Microtubule‐Associated Protein τ Are Elevated in Alzheimer's Disease: A Radioimmuno‐Slot‐Blot Assay for Nanograms of the Protein , 1992, Journal of neurochemistry.
[31] K. Kosik,et al. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons , 1990, Nature.
[32] N. Hirokawa,et al. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA , 1989, The Journal of cell biology.
[33] S. Yen,et al. Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1. , 1988, The Journal of biological chemistry.
[34] J. Ávila,et al. Tau and neuron aging. , 2013, Aging and disease.
[35] R. Nixon,et al. Cytoskeleton of the nervous system , 2011 .
[36] Y. Barde,et al. Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.
[37] K. Banerjee,et al. Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells. , 2000, Journal of Alzheimer's disease : JAD.